Comparative Analysis of Human B Cell Epitopes Based on BCG Genomes

Area of Science:

• Immunology
• Vaccinology
• Genetics

Background:

• Tuberculosis (TB) remains a significant global health challenge.
• Bacillus Calmette-Guérin (BCG) is the sole vaccine against TB, used for a century.
• Variability in BCG vaccine protection across populations necessitates understanding its genetic basis.

Purpose of the Study:

• To investigate the genetic differences among BCG subtypes.
• To understand the distribution of B cell epitopes in BCG strains.
• To identify potential reasons for the variable efficacy of BCG vaccines.

Main Methods:

• Collected human B cell epitope data from the Immune Epitope Database.
• Mapped epitope sequences against 15 genomes, including 13 BCG subtypes, M. bovis, and M. tuberculosis.
• Analyzed the distribution and conservation of B cell epitopes across different strains.

Main Results:

• Identified 398 experimentally verified B cell epitopes.
• Found that 321 (80.7%) epitopes were conserved across BCG strains.
• Observed that 77 (19.3%) epitopes were lost to varying degrees in BCGs, suggesting a link to variable protective efficacy.

Conclusions:

• This study provides the first analysis of BCG genetic characteristics based on B cell epitopes.
• The distribution of B cell epitopes may significantly contribute to the variable efficacy of BCG vaccines.
• Restoring key antigens or effective B cell epitopes in BCG could enhance vaccine development strategies.